Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health Administration

By afschroeder • July 20, 2025

Green-Lott AY, Wadhwa A, Bailey AV, Kwan L, Haroldsen CL, Shelton JB, Lewis MS, Beenhouwer DO, Chamie K, Rose BS, Maxwell KN, Nickols NG, Yamoah K, Kelley MJ, Rebbeck TR, Schoen M, Rettig MB, Iyer HS, Garraway IP. Prostate cancer incidence and outcomes among Vietnam veterans receiving care in the Veterans Health Administration. Cancer. 2025 Aug 1;131(15):e70007. doi: 10.1002/cncr.70007. PMID: 40682278; PMCID: PMC12274657.

Tags: Agent Orange, Hematology/Oncology, Infectious Diseases, military exposures, prostate cancer, Publications, Veterans Administration, Vietnam veterans

Trastuzumab deruxtecan and the evolving role of human epidermal growth factor receptor 2-targeted antibody-drug conjugates in breast and ovarian cancer

Thaker SK, Silverstein J, Konecny GE, Bardia A. Trastuzumab deruxtecan and the evolving role of human epidermal growth factor receptor 2-targeted antibody-drug conjugates in breast[...]

Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinoma

Chan SL, Finn RS, Edeline J, Ogasawara S, Knox JJ, Daniele B, Ryoo BY, Merle P, Bouattour M, Lim HY, Chao Y, Yau T, Haber[...]

First-line tiragolumab plus atezolizumab and chemotherapy in patients with previously untreated, locally advanced unresectable or metastatic oesophageal cancer (MORPHEUS-EC): a randomised, open-label, phase 1b/2 trial

Sun JM, Chao Y, Kim SB, Rha SY, Evans TRJ, Strickland AH, Wainberg Z, Chau I, Pelles-Avraham S, Ajani J, Malhotra R, Liu Q, Li[...]